Merck & Co Inc (NYSE:MRK)
| 78.24 Delayed Data As of May 14 |  -0.05 / -0.06%Today’s Change | 71.72 Today|||52-Week Range 87.80 | -4.35% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 78.29 |
| Today’s open | 79.05 |
| Day’s range | 78.24 - 79.22 |
| Volume | 7,894,197 |
| Average volume (3 months) | 11,861,710 |
| Market cap | $198.5B |
Data as of 4:00pm ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | -27.21% |
| Earnings growth (this year) | +8.64% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | +3.06% |
| P/E ratio | 28.3 |
| Price/Sales | 4.33 |
| Price/Book | 7.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.04 | +0.04% |
| ABBVAbbVie | -0.04 | -0.03% |
| LLYEli Lilly and Co | +0.14 | +0.07% |
| PFEPfizer | -0.03 | -0.07% |
Data as of 7:30pm ET, 05/14/2021
Financials
| Next reporting date | July 29, 2021 |
| EPS forecast (this quarter) | $1.60 |
| Annual revenue (last year) | $48.0B |
| Annual profit (last year) | $7.1B |
| Net profit margin | 14.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
